Illinois R&D tax credit: 6.5% on the increment

Illinois runs a modest, conventional research credit: 6.5% of qualifying expenditures in Illinois above a base amount, as of mid-2026, using federal Section 41 definitions, claimed self-serve on the income tax return, with a five-year carryforward and no refund or transfer. The design is easy; the two Illinois-specific facts worth holding are the rolling three-year base and the statutory sunset. Confirm both with the Illinois Department of Revenue before relying on any figure.

Computation: a simple incremental machine

Qualified research takes its federal meaning — the four-part test and QRE categories carry over from the federal claim — restricted to research performed in Illinois. The base is the average of qualifying in-state expenditures for the prior three years, and the credit is 6.5% of the current year's excess over that average. The consequence of a rolling-average base is worth internalizing: a company with flat Illinois research spending earns approximately nothing, while a company ramping in-state R&D earns the rate on most of the growth — and each strong year raises the next year's base. Compare that with volume-style credits in the dimension framework: Illinois is purely a growth incentive.

A worked illustration of the rolling base (illustrative figures):

The same $4.0M of 2026 spending after three flat $4.0M years would produce a credit of zero — the whole benefit lives in the delta.

Monetization

The credit offsets Illinois income tax; unused amounts carry forward five years, with no carryback, no refundability, and no transfer mechanism. Pass-through entities pass the credit to partners and shareholders under Illinois's flow-through rules, which broadens who can use it relative to corporation-tax-only states like New Jersey. Still, the five-year window is short: a loss company should discount accrued Illinois credits heavily in any model, since a credit that cannot meet Illinois tax within five years is worth face value of nothing. The multistate strategy guide covers when a short-carryforward state clears the claim-or-skip threshold.

Who benefits

Companies growing their Illinois research footprint — new labs, expanding engineering headcount, reshored development — with current or near-term Illinois tax liability. The self-serve mechanics (a schedule with the return, no application, no pool) keep marginal cost low, so even mid-sized increments are usually worth claiming when federal workpapers already carry state-of-performance tags. Poor fits: flat spenders (no increment), loss companies beyond a five-year profitability horizon, and thin-sliver multistate filers for whom base reconstruction costs more than 6.5% of a small delta returns.

The trap: the sunset

Illinois's credit is not permanent law. It operates under a sunset date that the General Assembly has extended repeatedly — and, in one earlier stretch, allowed to lapse before retroactively reinstating. As of mid-2026 the credit is in effect, but multi-year R&D siting decisions premised on the Illinois credit should treat the sunset as a live legislative variable and verify the current expiration with the Department of Revenue each cycle. The subsidiary trap is the base: three years of Illinois-sourced history is required, and companies that only recently began tagging QREs by state tend to overstate the increment by understating the base — a computation examiners check first.